University Bookshop Limited (In Liquidation) is in liquidation from 2 July 2025 and will be trading during the start of Semester Two. During this time only stock on hand can be purchased. No special orders will be made. No credits or gift vouchers can be redeemed. No returns will be accepted

Introduction to Market Access for Pharmaceuticals

SKU: 9781138032187
Regular price $271.00
Unit price
per
  • Author:
    Mondher Toumi
  • ISBN:
    9781138032187
  • Publication Date:
    January 2017
  • Edition:
    1
  • Pages:
    204
  • Binding:
    Paperback
  • Publisher:
    CRC Press
  • Country of Publication:
    United Kingdom
Introduction to Market Access for Pharmaceuticals
Introduction to Market Access for Pharmaceuticals

Introduction to Market Access for Pharmaceuticals

SKU: 9781138032187
Regular price $271.00
Unit price
per
  • Author:
    Mondher Toumi
  • ISBN:
    9781138032187
  • Publication Date:
    January 2017
  • Edition:
    1
  • Pages:
    204
  • Binding:
    Paperback
  • Publisher:
    CRC Press
  • Country of Publication:
    United Kingdom

Description

Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers’ needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University.

(0 in cart)
Shipping calculated at checkout.

You may also like

  • Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers’ needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University.

Market access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers’ needs, the drug will fail to reach its intended market value. Introduction to Market Access for Pharmaceuticals is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University.